What is the Share Price of Aurobindo Pharma Ltd?

Aurobindo Pharma Ltd share price is ₹1,229.10 As on 02 May, 2025|08:36

Home
>
Stocks
>
Aurobindo Pharma Ltd

Aurobindo Pharma Ltd Share Price

Q: What is the Market Cap of Aurobindo Pharma Ltd?

The Market Cap of Aurobindo Pharma Ltd is ₹72,018 As on 02 May, 2025|08:36

Q: What is PE Ratio of Aurobindo Pharma Ltd?

The P/E ratio of Aurobindo Pharma Ltd is 20.3 As on 02 May, 2025|08:36

Q: What is PB Ratio of Aurobindo Pharma Ltd?

The PB ratio of Aurobindo Pharma Ltd is 2.33 As on 02 May, 2025|08:36

₹ 1,229.10 +19.50 (1.61%)
Updated on 02-05-2025 8:25 AM

Stock Rating

Pros 3

Cons 5

Option Chain

Aurobindo Pharma Ltd Price Performance

Day's Low
₹1,212

Day's High
₹1,235

₹ 1,229.10

52-w low
₹1,010

52-w high
₹1,592

1,229.10

Day's open
₹1,213.30
Previous close
₹1,209.60
VWAP
₹1,227.13
Lower price band
₹1,106.20
Upper price band
₹1,352

Today's Market Action

The last traded share price of Aurobindo Pharma Ltd was 1,229.10 up by 1.61% on the NSE. Its last traded stock price on BSE was 1,229.40 up by 1.63%. The total volume of shares on NSE and BSE combined was 1,134,486 shares. Its total combined turnover was Rs 139.21 crores.

Aurobindo Pharma Ltd Medium and Long Term Market Action

Aurobindo Pharma Ltd hit a 52-week high of 1,592 on 13-09-2024 and a 52-week low of 1,010 on 07-04-2025. The stock price of Aurobindo Pharma Ltd is up by 7% over the last one month. It is up by 6.88% over the last one year. Don't forget to check the full stock price history in the table below.

Aurobindo Pharma Ltd Fundamentals

Market Cap (Cr): 72018
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Aurobindo Pharma Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Aurobindo Pharma Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Aurobindo Pharma Ltd

Data not available.

Aurobindo Pharma Ltd FAQ's

What is Share Price of Aurobindo Pharma Ltd?

What is the Market Cap of Aurobindo Pharma Ltd?

What is PE Ratio of Aurobindo Pharma Ltd?

What is PB Ratio of Aurobindo Pharma Ltd?

What is the CAGR of Aurobindo Pharma Ltd?

How to Buy Aurobindo Pharma Ltd Share?

Can I buy Aurobindo Pharma Ltd from Samco?

How do I buy Aurobindo Pharma Ltd from Samco?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Above Average Sustainable RoE
The company generates a sustainable return on equity greater than the expected cost of capital which implies that the underlying business can create and compound value over a period time due to it's ability to generate above average return on capital.
High Pricing Power
The business enjoys a relatively high pricing power and is able to withstand competitive pressure which works as a great moat for equity shareholders of the company.
Above Average Growth Rate
The company is estimated to grow its earnings at a reasonable rate over the next few years which will drive shareholder value creation

Cons

Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Poor Cash Flow Conversion
The business has very poor cash conversion ratio of only 39.32% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
Capital Intensive Business
The company operates an extremely capital intensive business with a low Asset turnover ratio of 1.47. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
Poor Working Capital Cycle
The company has a very poor working capital cycle of 216 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
High Promoter Pledge
The company has a relatively high promoter pledge to the extent of 17% of the total company's shareholding which can have a significantly negative impact on stock.

Valuation Analysis

Margin of safety
(02/05/2025)

104

Margin of Safety Index: High

78.38%

78.38% People are bullish about Aurobindo Pharma Ltd

21.62%

21.62 % People are bearish about Aurobindo Pharma Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %